About Matt Hardwick

Dr. Hardwick is a thought leader in the field of infection prevention in the healthcare environment of care and is an expert in antimicrobial surface technologies. He has 20 years of academic research experience, at Georgetown University where he completed his PhD in Cell Biology, and at Johns Hopkins University, where he completed 2 postdoctoral fellowships, one in the Bloomberg School of Public Health and the second in the James Buchanan Brady Urological Institute. Dr. Hardwick’s last academic appointment was with the MedStar Health Research Institute where he worked on numerous research initiatives including the use of antimicrobial surfaces in clinical healthcare environments. He is widely published, including several articles on the use of antimicrobials in clinical environments and the role of microbial surface contamination on infection rates in clinical settings.

In 2014, he left academia and started ResInnova Laboratories, a testing facility servicing healthcare among other industries. ResInnova’s work in healthcare revolves around reducing the impact of microbes on both soft and hard surfaces. The lab has worked extensively with products incorporating antimicrobial chemistries such as detergents, disinfectants, textiles to name a few. They have also have vast experience testing the antimicrobial efficacy of ultraviolet light. The laboratory works with many healthcare-relevant microorganisms such as Clostridium difficile (C diff; both spores and vegetative cells), Staphylococcus aureus (both methicillin-resistant and -sensitive), Escherichia coli, Klebsiella pneumoniae plus many more. Their work has led to the redesign of several products and lead to one client receiving 510(k) clearance as a Class II medical device from the U.S. Food and Drug Administration (FDA).